The pharmaceutical industry exports in Germany have shown significant growth over the past decade, with a notable increase from $75.28 billion in 2013 to $130.17 billion in 2023. The industry reached a peak CAGR of 9.32% in 2021, driven by the demand surge during the pandemic. Recent trends indicate a stabilizing growth with modest year-on-year variations of 4.52% in 2022 and 4.34% in 2023. The projected exports for 2024-2028 forecast steady growth, though at a reduced CAGR of 2.92%.
Future trends to watch for include:
- Innovations in biotechnology and personalized medicine, potentially boosting export values.
- Global regulatory changes and trade policies impacting market access and competitiveness.
- Sustainable practices and green technologies becoming more prevalent in manufacturing processes.
- Increased investment in digital health tools and telemedicine services driving sector growth.
